Pharmsville (318010) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Pharmsville (318010) reported revenue of 12.7 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202512.7 billion KRW-673 million KRW2.9 billion KRW[source]
202416.7 billion KRW-258 million KRW1.6 billion KRW[source]
202321.4 billion KRW1.6 billion KRW3.3 billion KRW[source]
202226.1 billion KRW4.1 billion KRW4.1 billion KRW[source]
202139.0 billion KRW6.2 billion KRW5.0 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202568.6 billion KRW1.9 billion KRW66.6 billion KRW[source]
202467.5 billion KRW2.5 billion KRW65.0 billion KRW[source]
202371.6 billion KRW7.2 billion KRW64.4 billion KRW[source]
202275.2 billion KRW12.2 billion KRW63.0 billion KRW[source]
202174.7 billion KRW15.0 billion KRW59.7 billion KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
20251.9 billion KRW-17.2 billion KRW-782 million KRW[source]
2024-347 million KRW15.6 billion KRW-3.0 billion KRW[source]
20234.7 billion KRW-10.7 billion KRW-6.7 billion KRW[source]
20225.2 billion KRW521 million KRW-1.5 billion KRW[source]
20218.3 billion KRW-2.6 billion KRW-1.2 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice